ABIVAX (EPA:ABVX) | WebDisclosure

Basculer en Français

10066	Companies
205769	Keywords
136028	Articles
109101	Press releases

Home
Companies
ABIVAX

PRESS RELEASE

published on 05/08/2024 at 08:30, 1 year 10 months ago

Abivax announces presentation of four abstracts for obefazimod in ulcerative colitis and preclinical colon cancer model at Digestive Disease Week 2024
Abivax announces presentation of four abstracts for obefazimod in ulcerative colitis and preclinical colon cancer model at Digestive Disease Week 2024. The event will showcase new data on obefazimod's impact and mechanism of action

Abivax Obefazimod Ulcerative Colitis Colon Cancer Digestive Disease Week 2024
BRIEF

published on 05/07/2024 at 22:05, 1 year 10 months ago

Abivax Announces Availability of Documents for Upcoming General Meeting

Biotechnology Shareholder Information Corporate Governance Abivax General Meeting
BRIEF

published on 05/07/2024 at 22:05, 1 year 10 months ago

Abivax annonce la mise à disposition des documents pour la prochaine assemblée générale

Biotechnologie Abivax Assemblée Générale Gouvernance D'Entreprise Informations Pour Les Actionnaires
PRESS RELEASE

published on 05/07/2024 at 22:01, 1 year 10 months ago

Abivax assemblée générale ordinaire annuelle et extraordinaire du 30 mai 2024 - Mise à disposition des documents préparatoires
Abivax annonce la tenue de son assemblée générale annuelle et extraordinaire le 30 mai 2024 à Paris. Mise à disposition des documents préparatoires pour les actionnaires

Biotechnologie Abivax Obefazimod Assemblée Générale Documents Préparatoires
PRESS RELEASE

published on 05/07/2024 at 22:00, 1 year 10 months ago

Abivax annual ordinary and extraordinary general meeting of May 30, 2024 - Availability of the preparatory documents
Abivax informs shareholders of its ordinary and extraordinary general meeting on May 30, 2024, providing access to preparatory documents and details on participation. Obefazimod and Abivax information included

Abivax Obefazimod General Meeting Clinical-stage Biotechnology Preparatory Documents
PRESS RELEASE

published on 05/07/2024 at 22:00, 1 year 10 months ago

Abivax annual ordinary and extraordinary general meeting of May 30, 2024 - Availability of the preparatory documents
Abivax announces its annual ordinary and extraordinary general meeting on May 30, 2024, with preparatory documents available for shareholders. The meeting details, including agenda and resolutions, are accessible on the company's website

Shareholders Biotechnology Abivax General Meeting Preparatory Documents
PRESS RELEASE

published on 05/07/2024 at 22:00, 1 year 10 months ago

Abivax assemblée générale ordinaire annuelle et extraordinaire du 30 mai 2024 - Mise à disposition des documents préparatoires
Abivax annonce son assemblée générale annuelle et extraordinaire du 30 mai 2024 avec la mise à disposition des documents préparatoires. L'événement se tiendra à Paris

Biotechnologie Abivax Assemblée Générale Traitements Thérapeutiques Documents Préparatoires
BRIEF

published on 04/30/2024 at 18:05, 1 year 10 months ago

ABIVAX rapporte le nombre d'actions et de droits de vote au 31 mars 2024

Autorité Des Marchés Financiers Droits De Vote Capital Social Abivax Informations Réglementaires
BRIEF

published on 04/30/2024 at 18:05, 1 year 10 months ago

ABIVAX reports the number of shares and voting rights as of March 31, 2024

Share Capital Voting Rights Financial Markets Authority Abivax Regulatory Information
PRESS RELEASE

published on 04/30/2024 at 18:00, 1 year 10 months ago

ABIVAX: Nombre d’actions composant le capital social et nombre total de droits de vote au 31.03.24.
ABIVAX communique le nombre d'actions et de droits de vote au 31.03.24, conformément aux dispositions réglementaires. Abivax est une société de biotechnologie axée sur le développement de traitements thérapeutiques

Droits De Vote Capital Social Biotechnologie Abivax Traitements Thérapeutiques

Accesswire

Published on 03/23/2026 at 14:05, 2 hours 7 minutes ago

Wellgistics Health Inc. Signs $105,000,000 Letter of Intent to Evaluate Potential Acquisition of Neuritek Therapeutics, Inc. which is Pioneering Innovative Therapies for Neurological and Psychiatric Disorders
Published on 03/23/2026 at 14:00, 2 hours 12 minutes ago

BlackBerry AtHoc Advances Command Center for Faster Response and Tighter Control During Critical Operations
Published on 03/23/2026 at 13:05, 3 hours 7 minutes ago

SouthGobi Announces Disclosable and Connected Transaction Deferral of Payment Obligations Under Convertible Debenture and Amended and Restated Cooperation Agreement
Published on 03/23/2026 at 12:32, 3 hours 40 minutes ago

Sinopec Announced 2025 Annual Results Annual Payout Ratio Reached 81%
Published on 03/23/2026 at 12:30, 3 hours 42 minutes ago

Digi Power X to Announce 2025 Year End Financial Results on March 31st

View all ACCESSWIRE

EQS Group

Published on 03/23/2026 at 15:05, 1 hour 6 minutes ago

Heidrick & Struggles Launches Heidrick Immersive, an AI-Enhanced Platform for Observing Leadership in Motion
Published on 03/23/2026 at 14:41, 1 hour 30 minutes ago

CEWE increases dividend for 17 consecutive years
Published on 03/23/2026 at 14:30, 1 hour 41 minutes ago

Solvias Earns EcoVadis Bronze Medal, Ranking in Top 35% of Companies for Sustainability Performance
Published on 03/23/2026 at 14:30, 1 hour 42 minutes ago

Belvilla Expands in Germany with Hambachtal Holiday Park in Oberhambach
Published on 03/23/2026 at 14:24, 1 hour 47 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Spire Healthcare Group plc

Les Echos

Published on 03/23/2026 at 08:10, 8 hours 2 minutes ago

Entrée en négociations exclusives de cession de la participation dans Winncare
Published on 03/20/2026 at 19:00, 2 days 21 hours ago

AXA - Conditions for availability or consultation of information relating to AXA’s Shareholders’ Meeting of April 30, 2026
Published on 03/20/2026 at 19:00, 2 days 21 hours ago

AXA - Modalités de mise à disposition ou de consultation des informations relatives à l’Assemblée Générale du 30 avril 2026
Published on 03/20/2026 at 18:15, 2 days 21 hours ago

Publication of AXA’s 2025 Universal Registration Document
Published on 03/20/2026 at 18:15, 2 days 21 hours ago

Mise à disposition du Document d’Enregistrement Universel 2025 d’AXA

View all LES ECHOS COMFI WIRE